Last reviewed · How we verify

NCT06630455

Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia

Recruiting now NA Last updated 3 June 2025
What this trial tests

NA trial testing Meu-cinn in Functioanl Dyspepsia in 100 participants. Currently enrolling.

Timeline
4 December 2024
Primary endpoint
30 December 2025
31 December 2025

Quick facts

Lead sponsorPusan National University Yangsan Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment100
Start date4 December 2024
Primary completion30 December 2025
Estimated completion31 December 2025
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Pusan National University Yangsan Hospital

Who can join

Adults 19 to 70, any sex, with Functioanl Dyspepsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to determine whether Meu-cinn promotes gastric mucosal health in adults with functional dyspepsia and to assess its safety. The main questions are: * Does Meu-cinn promote gastric mucosal health in participants? * What side effects occur when participants take Meu-cinn?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Pusan National University Yangsan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06630455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing